Bayer's SunHARBO® (ASundexian), 50 mg tablets, the first and only Factor XIa Inhibitor, approved by the US FDA to reduce the risk of stroke in adults with non-cardioembolic ischemic stroke or high-risk transient ischemic attack.
🇺🇸 USA · Map
Bayer's SunHARBO® (ASundexian), 50 mg tablets, the first and only Factor XIa Inhibitor, approved by the US FDA to reduce the risk of stroke in adults with non-cardioembolic ischemic stroke or high-risk transient ischemic attack.
Want to see every report in real time?
Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.
Sign up free Already have an account? Log in